Skip to main content

Find Clinical Trials

Home
Conditions
Appendiceal Neoplasms

Clinical trial condition

Appendiceal Neoplasms

Explore clinical trials studying Appendiceal Neoplasms. Study availability and eligibility vary by location and protocol.

70 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Appendiceal Neoplasms trial results

Recruiting

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

NCT05919758

Conditions: Appendiceal Neoplasms, Appendix Cancer, Cecal Diseases, +9 more
Locations: Amsterdam UMC Amsterdam-Zuidoost, Netherlands

View Trial Details

Not yet recruiting

The Prevalence of Appendiceal Tumours in Periappendicular Abscess

NCT04634448

Conditions: Appendiceal Neoplasms, Appendicitis, Appendix Abscess, +18 more
Locations: Not specified

View Trial Details

Active, not recruiting

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

NCT05277766

Conditions: Abdominal Neoplasms, Adenocarcinoma, Appendiceal Neoplasms, +37 more
Locations: UZ Ghent Ghent, East-Flanders, Belgium

View Trial Details

Active, not recruiting

Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

NCT01946854

Conditions: Appendiceal Neoplasms, Cecal Diseases, Cecal Neoplasms, +8 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors

NCT05462717

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +60 more
Locations: Highlands Oncology Group Springdale, Arkansas, United States

UC Irvine Cancer Center Orange, California, United States

UC Davis Cancer Center Sacramento, California, United States

UCSF San Francisco, California, United States

View all 64 locations

View Trial Details

Active, not recruiting

JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation

NCT05194995

Conditions: Advanced Colorectal Cancer, Appendiceal Cancer, Appendiceal Neoplasms, +11 more
Locations: Research site31 Beijing, Beijing Municipality, China

Research site01 Beijing, Beijing Municipality, China

Research site02 Beijing, Beijing Municipality, China

Research site12 Beijing, Beijing Municipality, China

View all 17 locations

View Trial Details

Active, not recruiting

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

NCT01815359

Conditions: Appendiceal Neoplasms, Appendix Cancer, Cecal Diseases, +13 more
Locations: University of Miami Miami, Florida, United States

Washington University School of Medicine St Louis, Missouri, United States

Memorial Sloan Kettering Basking Ridge (Consent and Follow up) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Consent and Follow up) Middletown, New Jersey, United States

View Trial Details

Active, not recruiting

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

NCT04157322

Conditions: Appendiceal Neoplasms, Appendix Cancer, Cecal Diseases, +15 more
Locations: The University of Chicago Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

NCT05623787

Conditions: Abdominal Neoplasms, Appendiceal Neoplasms, Appendix Cancer, +22 more
Locations: CIUSSS de l'Est-de-l'Île-de-Montréal Montreal, Quebec, Canada

CHU de Québec Québec, Quebec, Canada

View Trial Details

Active, not recruiting

Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin

NCT02387203

Conditions: Adenocarcinoma, Adenocarcinoma, Mucinous, Appendiceal Neoplasms, +15 more
Locations: Mercy Medical Center Baltimore, Maryland, United States

View Trial Details